Industry Talk

Rajiv Gandhi Cancer Institute and Research Centre

Rajiv Gandhi Cancer Institute and Research Centre strengthens its imaging capability with ‘MAGNETOM Vida’, the first MRI with BioMatrix Technology in Delhi and NCR region

Rajiv Gandhi Cancer Institute and Research Centre are one of the premier cancer centers in Asia founded in the year 1996. The institute offers cutting-edge technology and renowned specialists for patients from India and neighboring countries. It specializes in tertiary care services in Medical, Surgical, and Radiation Oncology, streamlined into dedicated site-specific teams. The hospital has reached a landmark of 25 years since its inception and is all set to begin yearlong silver jubilee celebrations in July 2021. This coincides with the acquisition of a most advanced 3Tesla MRI and a high-end Cath Lab optimized for Interventional Oncology.

The institute hosts Interventional Oncology as a dedicated service line which is widely acclaimed as the fourth pillar in cancer care. RGCIRC is one of the first hospitals in India to bring robotic surgery for cancer patients, pioneer ablative therapies with RFA and MWA, install true beam for precision radiotherapy, and set up a molecular laboratory. RGCIRC recently installed the first BioMatrix 3T MR System from Siemens Healthineers named MAGNETOM Vida. This is the first BioMatrix System installed in Delhi and NCR region and is most suited for cancer imaging.

RGCIRC recently installed the first BioMatrix 3T MR System from Siemens Healthineers named MAGNETOM Vida. This is the first BioMatrix System installed in Delhi and NCR region and is most suited for cancer imaging.

Patients are unique and have individual characteristics. The individual characteristics and anatomies may cause unwarranted variations in imaging results. The most recent and unique BioMatrix Technology helps to overcome these challenges by automatically adjusting to patient biovariability.

We are confident that the recent Installation of MAGNETOM Vida will certainly set a new benchmark in oncology imaging and this would help us deliver individualized & personalized care to all our patients with the help of BioMatrix technology. We had some challenges with scanning patients with limited breath-hold capability. New revolutionary free breathings abdomen examination has brought in a new paradigm shift in abdomen screening with high-resolution dynamic abdominal imaging under free-breathing with one continuous, push-button exam. New and Unique 64 channel Head Neck coil can now help us in improving our clinical results and speed by multifold”, said Dr. Arvind K Chaturvedi, Chair Radiology and Interventional Oncology at RGCIRC.

“MAGNETOM Vida effectively combines a unique Biomatrix technology which adapts automatically to bio-variability that enables personalized examinations and helps expand precision medicine. Coupled with an AI-based Dot engine it provides precise automated planning. New advanced platform and turbo packages help in performing scans up to 50% faster compared to any conventional scanners,” said Subodh Divgi, Head of MRI business at Siemens Healthineers, India.

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. In fiscal 2020, which ended on September 30, 2020, Siemens Healthineers generated revenue of €14.5 billion and an adjusted EBIT of €2.2 billion. Following the acquisition of Varian Medical Systems, Inc. the company has approximately 66,000 employees worldwide. Further information is available at www.siemens-healthineers.com.

Siemens Healthineers in India is Great Place to Work® certified, with over 3600 employees across the nation. With 56 sales offices, two manufacturing facilities at Vadodara for the Diagnostics business and at Bengaluru for Medical Imaging Products, we are supporting healthcare providers across the entire range of patient care – from prevention and early detection to diagnosis and on to treatment and aftercare. With a state-of-the-art R&D center as well as a global software development center at Bengaluru, country-wide sales network, and around-the-clock service setup; we are playing a significant role in transforming care delivery in India. Further information is available at www.siemens-healthineers.co.in 

Related Articles

Leave a Reply